Researchers at the University of São Paulo (USP) have identified 45 previously unknown toxins produced by Salmonella bacteria, a discovery that could influence future antibiotic development and biotechnology. The team, based at the Center for Research in Bacterial and Bacteriophage Biology (B3 RIDC), analyzed 6,165 Salmonella samples to map these microscopic “spear-like” defense systems. The findings were published in the journal PLOS Biology.
How does Salmonella use these toxins to compete?
Salmonella utilizes a specialized mechanism known as the type VI secretion system (T6SS) to maintain its position in competitive environments. According to the study published in PLOS Biology, this system functions like a molecular spear, injecting toxins into the environment or directly into competing microorganisms. Robson Francisco de Souza, a lead researcher at the B3 RIDC, notes that these effectors are essential for the bacterium to secure resources and space. The research team identified 128 distinct toxin types, with 45 being entirely new to science, suggesting that the “arms race” between bacteria is far more complex than previously understood.
The study found that Salmonella groups living in natural environments possess a higher number of these toxins than those collected from human patients. This suggests that the bacteria “upgrade” their genetic arsenal based on the intensity of competition in their specific habitat.
Why does this matter for future antibiotic development?
The discovery of these novel toxins provides a blueprint for scientists working to develop next-generation antibiotics. Because many eukaryotic proteins share evolutionary origins with bacterial toxins, these molecules could be repurposed for clinical or biotechnological applications. Souza emphasizes that the diversity of these toxins is immense, with new varieties constantly emerging through gene recombination. By mapping these sequences, researchers hope to identify how specific strains target cells, potentially opening new pathways to disrupt harmful bacteria without damaging human hosts.
What are the next steps for bacterial research?
The research team at USP is currently developing automated software to expand this analysis to other organisms, including archaea and less-studied bacterial lineages. The goal is to move beyond Salmonella and understand how toxins dictate ecological interactions across the microbial world. According to the São Paulo Research Foundation (FAPESP), which supports the B3 RIDC, these digital pipelines will allow scientists to process vast genetic datasets more efficiently, speeding up the identification of compounds that could eventually become life-saving medical treatments.
Frequently Asked Questions
- Are these 45 new toxins dangerous to humans?
Some of the identified molecules affect eukaryotic cells, which include human cells. However, researchers have not yet confirmed which specific strains target humans or the extent of their impact on clinical infections. - How were these toxins discovered?
The team used computational tools to analyze the genetic data of 6,165 Salmonella enterica samples, comparing protein sequences to identify unique, previously undescribed toxins. - Why is this considered an “arms race”?
Bacteria engage in constant biological conflict for limited resources. As they face new adversaries, they evolve and select for new toxins to maintain their survival, creating a cycle of constant defensive and offensive adaptation.
Have questions about the future of antibiotic research or the role of bacterial genetics in medicine? Explore our latest science reports or subscribe to our newsletter for updates on biotechnology breakthroughs.
